Levaquin, Levofloxacin

Levaquin, Levofloxacin Newswire

Comprehensive Real-Time News Feed for Levaquin, Levofloxacin (generic).

Results 1 - 20 of 67 in Levaquin, Levofloxacin (generic)

  1. Report Published: "China Resources Double-Crane Pharmaceutical Co., Ltd."Read the original story

    1 hr ago | PR-inside.com

    China Resources Double-Crane Pharmaceutical Co., Ltd. , formerly Beijing Double-Crane Pharmaceutical Co., Ltd., is a pharmaceutical company. The company carries out the manufacturing, processing and distributing pharmaceuticals.

    Comment?

  2. Gimme Shelter: CommonRead the original story w/Photo

    20 hrs ago | Shelter Island Reporter

    Yeah, I know, poor baby. That's one symptom of a cold that has nothing to do with crankiness and Kleenex - the chance to play Poor Pitiful Me for a while.

    Comment?

  3. FDA Approves Zerbaxa (ceftolozane/tazobactam) for Complicated...Read the original story w/Photo

    Dec 19, 2014 | Drugs.com

    December 19, 2014 -- The U.S. Food and Drug Administration today approved Zerbaxa , a new antibacterial drug product, to treat adults with complicated intra-abdominal infections and complicated urinary tract infections . Zerbaxa is a combination product containing ceftolozane, a cephalosporin antibacterial drug, and tazobactam, a beta-lactamase inhibitor.

    Comment?

  4. High penicillin prescribing could build reservoirs of resistanceRead the original story w/Photo

    Monday Jan 26 | PhysOrg Weblog

    High penicillin G prescribing may lead to an altered level of resistance in the commensal viridans group streptococci population, which may be important in subsequent horizontal gene transfer events, according to a study published online Jan. 21 in the Journal of Clinical Pharmacy and Therapeutics . Colin E. Goldsmith, M.B., B.Ch., from Belfast City Hospital in the United Kingdom, and colleagues examined the prescribing practices in general practice and their impact on antibiotic resistance .

    Comment?

  5. Tanzania: TFDA Orders Drugs DeshelvingRead the original story w/Photo

    Monday Jan 26 | AllAfrica.com

    TANZANIA Food and Drugs Authority has revoked licences for importation, sale and use of five categories of medicines due to safety concerns and at the same time restricted use of four groups of drugs. The medications include tablets and capsules of Ketoconazole drug which is used to treat fungus as well as tablets and syrup of anti-malaria medicine Amodiaquine monotherapy.

    Comment?

  6. Post-cataract endophthalmitis caused by multidrug-resistant...Read the original story

    Saturday Jan 24 | BioMed Central

    A retrospective case review from December 10, 2010 to April 7, 2011 was performed at the Eye & ENT Hospital, Fudan University. Data were collected for surgical details, disease characteristics, antibiotic sensitivity of the pathogen, and treatment response.

    Comment?

  7. Yabao Pharmaceutical Group Co., Ltd. (600351) - Pharmaceuticals &...Read the original story

    Sunday Jan 18 | PR-inside.com

    The company manufactures and markets pharmaceuticals products including western and Chinese medicines, APIs, and health care products. Its products include sennae leaf, senna pods, clove, rhubarb, compound zedoary turmeric oil suppositories, povidone iodine suppositories, povidone iodine solution, gemfibrozil capsules, levofloxacin hydrochloride injection, pefloxacin mesylate injection, asarone injection, potassium aspartate and magnesium aspartate injection, simvastatin tablets, propranolol hydrochloride, sustained-release tablets, lovastatin tablets, and mosapride citrate tablets, among others.

    Comment?

  8. Emergence and prevention measures for multidrug resistant Pseudomonas ...Read the original story

    Friday Jan 9 | Spinal Cord

    Correspondence: Dr K Shigemura, Division of Urology, Department of Organs Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. E-mail: yutoshunta@hotmail.co.jp To evaluate measures for preventing multidrug resistant Pseudomonas aeruginosa in catheter-associated urinary tract infection in spinal cord injury patients.

    Comment?

  9. New Market Report: Zhejiang Medicine Co., Ltd. (600216) -...Read the original story

    Thursday Jan 1 | PR-inside.com

    It develops, manufactures and markets high-quality biological drugs, pharmaceutical intermediates and bio-pesticides. The company's product portfolio consists of natural vitamin E soft capsules, synthetic vitamin E, levofloxacin lactate tablets, vancomycin hydrochloride for injection, progesterone soft capsules, beta carotene, and teicoplanin for injection.

    Comment?

  10. FDA approves new antibacterial drug ZerbaxaRead the original story w/Photo

    Dec 31, 2014 | Medical News Today

    The U.S. Food and Drug Administration has approved Zerbaxa , a new antibacterial drug product, to treat adults with complicated intra-abdominal infections and complicated urinary tract infections . Zerbaxa is a combination product containing ceftolozane, a cephalosporin antibacterial drug, and tazobactam, a beta-lactamase inhibitor.

    Comment?

  11. Report Published: "Bluefish Pharmaceuticals AB - Pharmaceuticals &...Read the original story

    Dec 28, 2014 | PR-inside.com

    The company develops, manufactures and markets generic pharmaceuticals. Its products include diclofenac BMM, naproxen BMM, tiparol BMM, ciprofloxacin bluefish, levofloxacin bluefish, terbinafine BMM, valaciclovir bluefish, perindopril BMM, baclofen bluefish, fentanyl bluefish, lamotrigine BMM, levetiracetam bluefish, mirtazapine bluefish, and relanio.

    Comment?

  12. Jiangsu Hengrui Medicine Co., Ltd. (600276) - Pharmaceuticals &...Read the original story

    Dec 23, 2014 | PR-inside.com

    It manufactures and distributes pharmaceutical products. Its product portfolio includes antineoplastic products such as ifosfamide injection, irinotecan hydrochloride for injection, methotextrate injection and leucovorin injection; cardiovascular therapeutics comprising enalapril maleate tablets, irbesartan tablets, aspirin/extended release dipyridamole capsules and verapamil hydrochloride sustained release tablets; endocrine drugs such as raloxifene hydrochloride tablets; antibiotics comprising clarithromycin tablets, roxithromycin tablets and levofloxacin; infusion products such as glucose injection, Ioversol injection and mannitol injection; and other products comprising ambroxol HCl tablets and zoledronic acid injection, among others.

    Comment?

  13. Now Available: Neuland Laboratories Limited (NEULANDLAB) -...Read the original story

    Dec 22, 2014 | PR-inside.com

    Neuland Laboratories Limited is a pharmaceutical company. It manufactures active pharmaceutical ingredients and advanced intermediates.

    Comment?

  14. Another new antibacterial approved to treat complicated abdominal infectionsRead the original story w/Photo

    Dec 21, 2014 | Examiner.com

    The USDA has given its seal of approval to the new antibactierial drug Zerbaxa , for the treatment of adults suffering from complicated intra-abdominal infections and complicated urinary tract infections including kidney infection. Basically a compound medication made up of ceftolozane and tazobactam , Zerbaxa is to be used in combination with metronidazole to treat cIAI.

    Comment?

  15. FDA approves new antibacterial drug ZerbaxaRead the original story

    Dec 19, 2014 | PressReleasePoint

    The U.S. Food and Drug Administration today approved Zerbaxa , a new antibacterial drug product, to treat adults with complicated intra-abdominal infections and complicated urinary tract infections . Zerbaxa is a combination product containing ceftolozane, a cephalosporin antibacterial drug, and tazobactam, a beta-lactamase inhibitor.

    Comment?

  16. UPDATE 2-Tetraphase's antibiotic succeeds late-stage trial, shares riseRead the original story

    Dec 17, 2014 | Reuters

    Tetraphase Pharmaceuticals Inc said its antibiotic to treat complicated intra-abdominal infections was as effective as Merck & Co Inc's ertapenem in a late-stage study. Tetraphase is also testing the drug against Johnson & Johnson's levofloxacin to treat complicated urinary tract infections in another late-stage study, the results of which are expected in mid-2015.

    Comment?

  17. Fulminant hepatic failure and acute renal failure as manifestations...Read the original story

    Dec 9, 2014 | BioMed Central

    Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, No 2, Ming-Shen Road, Dalin Town 622, Chia-Yi County, Taiwan Background Coxiella burnetii is an obligate bacterial pathogen that causes Q fever. Cytomegalovirus commonly exists as a latent infection in healthy people.

    Comment?

  18. Merck Triggers The Race to Replace CubistRead the original story

    Dec 8, 2014 | Forbes.com

    Steve Brozak is President of WBB Securities, LLC, an investment bank and research firm that specializes in the biotechnology, specialty pharmaceutical and medical device sectors. Mr. Brozak is an award winning analyst whose research has been singled out from his peers for accuracy and performance year after year by the financial industry's most highly regarded rankings organizations.

    Comment?

  19. Cempra Poised To Join Antibacterial Drug Acquisition Buzz With Upcoming Data ReleaseRead the original story w/Photo

    Nov 25, 2014 | Seeking Alpha

    Cempra's Solithromycin is also designed to potentially treat a wide array of bacterial infections, perhaps placing its potential value at the top of the developmental antibacterial company list. With Trius Pharma acquired by Cubist in late 2013, along with the very recent Tetraphase acquisition rumor buzz, Cempra is certain to join the fray if its data release proves.

    Comment?

  20. Use of antibiotic following kidney transplantation does not prevent virus infectionRead the original story w/Photo

    Nov 16, 2014 | Science Daily

    Among kidney transplant recipients, a 3-month course of the antibiotic levofloxacin following transplantation did not prevent the major complication known as BK virus from appearing in the urine. The intervention was associated with an increased risk of adverse events such as bacterial resistance, according to a study.

    Comment?